Guardant Health rises after $500 mln convertible bond sale
** Shares of precision oncology firm Guardant Health GH.O up 2.1% at $158 before the bell on Thurs after clinching capital raise
** GH early Thurs announces pricing private offering of $500 mln 0% convertible bonds (CBs) due May 15, 2032
** Conversion price of $208.95 is 35% premium to stock's last sale of $154.78 on Weds
** Co expects to use net offering proceeds to repurchase a portion of its 0% CBs due 2027
** GH intends to use remaining proceeds to fund $51.7 mln cost of capped call transactions; cap price is $309.56, double stock's last close
** Palo Alto, California-based GH has about $21 bln market cap
** Through Weds, stock up 51.5% YTD
** 25 of 27 analysts rate the stock "strong buy" or "buy", 2 "hold"; median PT is $200, per latest LSEG data